|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/573 | (2006.01) |
| A61K 31/495 | (2006.01) | ||
| A61K 31/41 | (2006.01) | ||
| A61K 31/341 | (2006.01) | ||
| A61K 31/435 | (2006.01) | ||
| A61P 9/00 | (2006.01) | ||
| A61P 25/02 | (2006.01) | ||
| A61P 25/28 | (2006.01) |
| (11) | Number of the document | 3185957 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15835924.0 |
| Date of filing the European patent application | 2015-08-27 | |
| (97) | Date of publication of the European application | 2017-07-05 |
| (45) | Date of publication and mention of the grant of the patent | 2022-06-01 |
| (46) | Date of publication of the claims translation | 2022-09-26 |
| (86) | Number | PCT/US2015/047185 |
| Date | 2015-08-27 |
| (87) | Number | WO 2016/033326 |
| Date | 2016-03-03 |
| (30) | Number | Date | Country code |
| 201462044100 P | 2014-08-29 | US | |
| 201562150596 P | 2015-04-21 | US |
| (72) |
BETTENCOURT, Brian , US
|
| (73) |
Alnylam Pharmaceuticals, Inc. ,
675 West Kendall Street
Henri A. Termeer Square, Cambridge, MA 02142,
US
|
| (74) |
Nelia JANIUŠINA,
UAB „FONDIA LIETUVA“ Gedimino pr. 20, LT-01103 Vilnius,
LT
|
| (54) | Patisiranas, skirtas naudoti transtiretino amiloidozei gydyti |
| PATISIRAN FOR USE IN TREATING TRANSTHYRETIN MEDIATED AMYLOIDOSIS |
| Payment date | Validity (years) | Amount | |
| 2025-08-06 | 11 | 289.00 EUR |
| 2026-08-27 |